Provided by Tiger Trade Technology Pte. Ltd.

Connect Biopharma Holdings Ltd.

1.10
+0.108010.89%
Post-market: 1.110.0094+0.85%19:00 EDT
Volume:165.39M
Turnover:263.81M
Market Cap:69.26M
PE:-0.92
High:1.89
Open:1.89
Low:1.07
Close:0.9920
52wk High:3.82
52wk Low:0.9800
Shares:62.96M
Float Shares:21.58M
Volume Ratio:117.10
T/O Rate:766.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1933
EPS(LYR):-1.0000
ROE:-140.51%
ROA:-69.75%
PB:2.58
PE(LYR):-1.10

Loading ...

Top Midday Gainers

MT Newswires Live
·
4 hours ago

Lake Street Sticks to Its Buy Rating for Connect Biopharma Holdings (CNTB)

TIPRANKS
·
Yesterday

Why Is Penny Stock Connect Biopharma (CNTB) Up 98% Today?

TIPRANKS
·
Yesterday

Connect Biopharma reports positive Phase 2 COPD results

TIPRANKS
·
Yesterday

Connect Biopharma announces results from global Phase 2 study of rademikibart

TIPRANKS
·
Yesterday

Connect Biopharma Says Phase 2 Trial Shows Rademikibart Cuts COPD Treatment Failure Rate 81% Through Week 4

Reuters
·
Yesterday

Connect Biopharma - Rademikibart Reduced Treatment Failure Rate by 81% Through One Month in Phase 2 Study

THOMSON REUTERS
·
Yesterday

Connect Biopharma - to Engage FDA for Phase 3 Program for Rademikibart in Copd

THOMSON REUTERS
·
Yesterday

Connect Biopharma Announces Positive Preliminary Topline Data from Its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with Copd and Type 2 Inflammation

THOMSON REUTERS
·
Yesterday

Connect Biopharma - Rademikibart Reduced Hospitalizations or Ed Visits for Acute Copd Exacerbations by 100%

THOMSON REUTERS
·
Yesterday

Connect Biopharma - Rademikibart Well Tolerated with Lower Incidence of Adverse Events than Placebo

THOMSON REUTERS
·
Yesterday

Connect Biopharma price target lowered to $5 from $8 at Oppenheimer

TIPRANKS
·
Sep 22

US Research Roundup-Boeing, Twilio, WP Carey

Reuters
·
Sep 22

H.C. Wainwright Sticks to Its Buy Rating for Connect Biopharma Holdings (CNTB)

TIPRANKS
·
Sep 22

Connect Biopharma Price Target Maintained with a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 17

Connect Biopharma price target lowered to $6 from $7 at Canaccord

TIPRANKS
·
Sep 16

U.S. Stocks on the MOVE-Forgent Power, Vera Bradley, Wells Fargo

Reuters
·
Sep 16

Connect Biopharma Price Target Maintained with a $10.00/Share by BTIG

Dow Jones
·
Sep 16

Connect Biopharma Falls After Asthma Drug Fails to Meet Main Goal in Early-Stage Study

Reuters
·
Sep 15

Connect Biopharma Announces Positive Preliminary Topline Data from Its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adult and Adolescent Participants with Asthma and Type 2 Inflammation

THOMSON REUTERS
·
Sep 15